Status:

COMPLETED

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma

Lead Sponsor:

4SC AG

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of the study is to determine whether 4SC-201 alone or in combination with Sorafenib is effective and safe in the treatment of hepatocellular carcinoma in patients refractory to Sorafenib m...

Eligibility Criteria

Inclusion

  • Main
  • Advanced stage hepatocellular carcinoma
  • Patients exhibiting progressive disease under Sorafenib treatment
  • Child-Pugh class A and B. Only patients with Child-Pugh index class B of not more than 7 will be included
  • ECOG performance status 0, 1 or 2
  • Precedent first-line treatment with Sorafenib minimum continuous dosing of 400 mg per day for at least 8 weeks
  • Main

Exclusion

  • Previous or concurrent cancer that is distinct in primary site or histology from HCC, EXCEPT cervical carcinoma in situ, treated basal cell carcinoma, superficial bladder tumors (Ta, Tis and T1) - any cancer curatively treated \> 3 years prior to entry is permitted
  • Renal failure requiring hemo- or peritoneal dialysis
  • Known central nervous system (CNS) tumors including symptomatic brain metastasis
  • Child-Pugh index class B in combination with more than slight ascites or hepatic encephalopathy \> Grade I
  • Pregnant or breastfeeding women
  • Sorafenib intolerance
  • Major surgery within the last 4 weeks

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT00943449

Start Date

July 1 2009

End Date

September 1 2013

Last Update

January 16 2014

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

ONKOPLUS Beratung und Hilfe für Menschen mit Krebs

Berlin, Germany, 14195

2

Universitätsklinikum Essen (Innere Klinik/Tumorforschung und Zentrum für Innere Medizin)

Essen, Germany, 45147

3

Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg (Klinik und Poliklinik für Innere Medizin I)

Halle, Germany, 06120

4

Universitätsklinikum Hamburg-Eppendorf (I. Medizinische Klinik und Poliklinik)

Hamburg, Germany, 20246